 | • レポートコード：QYR9ST07793 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ペンブロリズマブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、50mg注射、100mg注射に、用途別には、進行性黒色腫、頭頸部扁平上皮癌（HNSCC）、切除不能または転移性固形腫瘍、その他にセグメント区分し、ペンブロリズマブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ペンブロリズマブの世界市場概要 ・ペンブロリズマブの製造コスト構成分析 ・ペンブロリズマブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ペンブロリズマブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ペンブロリズマブのセグメント分析（種類別） （50mg注射、100mg注射） ・ペンブロリズマブのセグメント分析（用途別） （進行性黒色腫、頭頸部扁平上皮癌（HNSCC）、切除不能または転移性固形腫瘍、その他） ・ペンブロリズマブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Merck） ・ペンブロリズマブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Pembrolizumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pembrolizumab volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pembrolizumab market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pembrolizumab in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pembrolizumab manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
50mg Injection
100mg Injection
Segment by Application
Advanced Melanoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Unresectable or Metastatic Solid Tumor
Other
Table of Contents
Executive Summary
1 Industry Overview of Pembrolizumab
1.1 Definition of Pembrolizumab
1.2 Pembrolizumab Segment by Type
1.2.1 Global Pembrolizumab Production Growth Rate Comparison by Types (2014-2025)
1.2.2 50mg Injection
1.2.3 100mg Injection
1.3 Pembrolizumab Segment by Applications
1.3.1 Global Pembrolizumab Consumption Comparison by Applications (2014-2025)
1.3.2 Advanced Melanoma
1.3.3 Head and Neck Squamous Cell Carcinoma (HNSCC)
1.3.4 Unresectable or Metastatic Solid Tumor
1.3.5 Other
1.4 Global Pembrolizumab Overall Market
1.4.1 Global Pembrolizumab Revenue (2014-2025)
1.4.2 Global Pembrolizumab Production (2014-2025)
1.4.3 North America Pembrolizumab Status and Prospect (2014-2025)
1.4.4 Europe Pembrolizumab Status and Prospect (2014-2025)
1.4.5 China Pembrolizumab Status and Prospect (2014-2025)
1.4.6 Japan Pembrolizumab Status and Prospect (2014-2025)
1.4.7 Southeast Asia Pembrolizumab Status and Prospect (2014-2025)
1.4.8 India Pembrolizumab Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Pembrolizumab
2.3 Manufacturing Process Analysis of Pembrolizumab
2.4 Industry Chain Structure of Pembrolizumab
3 Development and Manufacturing Plants Analysis of Pembrolizumab
3.1 Capacity and Commercial Production Date
3.2 Global Pembrolizumab Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Pembrolizumab
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Pembrolizumab Production and Capacity Analysis
4.2 Pembrolizumab Revenue Analysis
4.3 Pembrolizumab Price Analysis
4.4 Market Concentration Degree
5 Pembrolizumab Regional Market Analysis
5.1 Pembrolizumab Production by Regions
5.1.1 Global Pembrolizumab Production by Regions
5.1.2 Global Pembrolizumab Revenue by Regions
5.2 Pembrolizumab Consumption by Regions
5.3 North America Pembrolizumab Market Analysis
5.3.1 North America Pembrolizumab Production
5.3.2 North America Pembrolizumab Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Pembrolizumab Import and Export
5.4 Europe Pembrolizumab Market Analysis
5.4.1 Europe Pembrolizumab Production
5.4.2 Europe Pembrolizumab Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Pembrolizumab Import and Export
5.5 China Pembrolizumab Market Analysis
5.5.1 China Pembrolizumab Production
5.5.2 China Pembrolizumab Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Pembrolizumab Import and Export
5.6 Japan Pembrolizumab Market Analysis
5.6.1 Japan Pembrolizumab Production
5.6.2 Japan Pembrolizumab Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Pembrolizumab Import and Export
5.7 Southeast Asia Pembrolizumab Market Analysis
5.7.1 Southeast Asia Pembrolizumab Production
5.7.2 Southeast Asia Pembrolizumab Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Pembrolizumab Import and Export
5.8 India Pembrolizumab Market Analysis
5.8.1 India Pembrolizumab Production
5.8.2 India Pembrolizumab Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Pembrolizumab Import and Export
6 Pembrolizumab Segment Market Analysis (by Type)
6.1 Global Pembrolizumab Production by Type
6.2 Global Pembrolizumab Revenue by Type
6.3 Pembrolizumab Price by Type
7 Pembrolizumab Segment Market Analysis (by Application)
7.1 Global Pembrolizumab Consumption by Application
7.2 Global Pembrolizumab Consumption Market Share by Application (2014-2019)
8 Pembrolizumab Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Pembrolizumab Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Pembrolizumab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
9 Development Trend of Analysis of Pembrolizumab Market
9.1 Global Pembrolizumab Market Trend Analysis
9.1.1 Global Pembrolizumab Market Size (Volume and Value) Forecast 2019-2025
9.2 Pembrolizumab Regional Market Trend
9.2.1 North America Pembrolizumab Forecast 2019-2025
9.2.2 Europe Pembrolizumab Forecast 2019-2025
9.2.3 China Pembrolizumab Forecast 2019-2025
9.2.4 Japan Pembrolizumab Forecast 2019-2025
9.2.5 Southeast Asia Pembrolizumab Forecast 2019-2025
9.2.6 India Pembrolizumab Forecast 2019-2025
9.3 Pembrolizumab Market Trend (Product Type)
9.4 Pembrolizumab Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Pembrolizumab Distributors List
10.3 Pembrolizumab Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Pembrolizumab
Table Global Pembrolizumab Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Pembrolizumab Production Market Share by Types in 2018
Figure 50mg Injection Product Picture
Figure 100mg Injection Product Picture
Table Global Pembrolizumab Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Pembrolizumab Consumption Market Share by Applications in 2018
Figure Advanced Melanoma
Figure Head and Neck Squamous Cell Carcinoma (HNSCC)
Figure Unresectable or Metastatic Solid Tumor
Figure Other
Figure Global Pembrolizumab Revenue (Million USD) (2014-2025)
Figure Global Pembrolizumab Production (K Pcs) (2014-2025)
Figure North America Pembrolizumab Market Size (Million USD) (2014-2025)
Figure Europe Pembrolizumab Market Size (Million USD) (2014-2025)
Figure China Pembrolizumab Market Size (Million USD) (2014-2025)
Figure Japan Pembrolizumab Market Size (Million USD) (2014-2025)
Figure Southeast Asia Pembrolizumab Market Size (Million USD) (2014-2025)
Figure India Pembrolizumab Market Size (Million USD) (2014-2025)
Table Pembrolizumab Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Pembrolizumab in 2018
Figure Manufacturing Process Analysis of Pembrolizumab
Figure Industry Chain Structure of Pembrolizumab
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Pembrolizumab Manufacturing Plants Distribution
Table Pembrolizumab Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Pembrolizumab Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Pembrolizumab Production (K Pcs) of Major Manufacturers (2014-2019)
Table Pembrolizumab Production Market Share of Major Manufacturers (2014-2019)
Figure Pembrolizumab Production Share by Manufacturers in 2018
Table Pembrolizumab Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Pembrolizumab Revenue Market Share of Major Manufacturers (2014-2019)
Figure Pembrolizumab Revenue Share by Manufacturers in 2018
Table Pembrolizumab Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Pembrolizumab Production by Regions 2014-2019 (K Pcs)
Table Global Pembrolizumab Production Market Share by Regions 2014-2019
Figure Global Pembrolizumab Production Market Share by Regions in 2018
Table Global Pembrolizumab Revenue by Regions 2014-2019 (Million USD)
Table Global Pembrolizumab Revenue Market Share by Regions 2014-2019
Figure Global Pembrolizumab Revenue Market Share by Regions in 2018
Table Global Pembrolizumab Consumption by Regions 2014-2019 (K Pcs)
Table Global Pembrolizumab Consumption Market Share by Regions 2014-2019
Figure North America Pembrolizumab Production Growth Rate 2014-2019 (K Pcs)
Figure North America Pembrolizumab Revenue Growth Rate 2014-2019 (Million USD)
Table North America Pembrolizumab Production, Consumption Import and Export (K Pcs)
Figure Europe Pembrolizumab Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Pembrolizumab Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Pembrolizumab Production, Consumption Import and Export (K Pcs)
Figure China Pembrolizumab Production Growth Rate 2014-2019 (K Pcs)
Figure China Pembrolizumab Revenue Growth Rate 2014-2019 (Million USD)
Table China Pembrolizumab Production, Consumption Import and Export (K Pcs)
Figure Japan Pembrolizumab Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Pembrolizumab Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Pembrolizumab Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Pembrolizumab Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Pembrolizumab Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Pembrolizumab Production, Consumption Import and Export (K Pcs)
Figure India Pembrolizumab Production Growth Rate 2014-2019 (K Pcs)
Figure India Pembrolizumab Revenue Growth Rate 2014-2019 (Million USD)
Table India Pembrolizumab Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Pembrolizumab Market Share by Application (2014-2019)
Figure Global Value (Consumption) Pembrolizumab Market Share by Application (2014-2019)
Table Merck Pembrolizumab Production Sites and Area Served
Table Merck Pembrolizumab Product Introduction, Application and Specification
Table Merck Pembrolizumab Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Pembrolizumab Production Growth Rate (2014-2019)
Table Merck Pembrolizumab Production Market Share (2014-2019)
Figure Merck Pembrolizumab Revenue Market Share (2014-2019)
Table Merck Pembrolizumab Main Business and Markets Served
Figure Global Pembrolizumab Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Pembrolizumab Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Pembrolizumab Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Pembrolizumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Pembrolizumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Pembrolizumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Pembrolizumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Pembrolizumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Pembrolizumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Pembrolizumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Pembrolizumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Pembrolizumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Pembrolizumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Pembrolizumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Pembrolizumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Pembrolizumab by Type (2019-2025)
Table Global Consumption (K Pcs) of Pembrolizumab by Application (2019-2025)
Table Pembrolizumab Distributors List
Table Pembrolizumab Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
進行腎細胞癌治療薬の世界市場：市場規模・現状・予測 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …- 世界のニボルマブ市場：専門的調査 The global Nivolumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Nivolumab volume and value at global level, regional level and company level. From a global perspective, this report re…
- 基底細胞癌治療の世界市場：市場規模・現状・予測 Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…
- 金属及びセラミック射出成形の世界市場：市場規模・現状・予測 Metal and ceramic injection molding is collectively known as powder injection molding. It combines both plastic-molded design flexibility and powder-molded material flexibility, which creates both ceramic and metal parts. This technology is majorly used for producing parts with high complex structur…
- 世界の硫酸プロタミン注射市場：専門的調査 Protamine Sulfate Injection, isotonic solution of protamine sulfate in Water for Injection, is a medication that is used to reverse the effects of heparin. It is specifically used in heparin overdose, in low molecular weight heparin overdose, and to reverse the effects of heparin during delivery and…